Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
| 03.12.26 | 6 min read
Sugizaki and Maria Margareth V
Vitamin C supplementation works synergistically with glutathione, as vitamin C helps regenerate glutathione while glutathione protects vitamin C from oxidation
When examining cagrilintide dosing strategies, researchers have found that the 2.4 mg weekly dose offers an optimal balance between efficacy and tolerability in many study populations
Collagen helps maintain the thickness and elasticity of the dermis, the skin's middle layer